HIV/AIDS

Study finds similar survival outcomes among NSCLC patients with and without HIV

Atul Gawande on how USAID's international relief helps us at home

New guidance ditches MSM-specific screening questions in effort to expand eligibility

Idiopathic CD4 lymphocytopenia not so heterogenous after all

New estimate says taxpayers spent over $140 million to study Truvada as HIV prevention

Both sides likely to appeal the ruling

But "significant gaps remain," says CDC researcher

While awaiting trial evidence, CDC summarizes the clinical considerations

Main focus now will be approaches using broadly neutralizing HIV-1 antibodies, researchers say

Trial shows noninferiority to daily antiretroviral pills for controlling HIV

Researchers argue that severe mpox is AIDS-defining; critics say that's stigmatizing

Half of kids under age 5 not diagnosed before death, CHAMPS study found

Substudy of HPTN 083 trial examined differences in outcomes by race among U.S. participants

Trial results came as a surprise after success in prophylaxis for other groups